F.D.A. Will Attach Warning of Rare Nerve Syndrome to Johnson & Johnson Vaccine

Federal regulators found that the risk of developing the syndrome was low, but three to five times higher among Johnson & Johnson vaccine recipients than the general population.

View original article
Contributor: Sharon LaFraniere and Noah Weiland